OrganiGram Holdings Inc
NASDAQ: OGI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
Updated 2026-04-29
OrganiGram Holdings Inc (OGI) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for OGI.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
OGI historical valuation range
Where current P/E sits in OGI's own 5Y range.
OGI intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
OGI valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 12.45x
P/S Ratio — History
Current: 0.69x
Is OGI overvalued in 2026?
OrganiGram Holdings Inc (OGI) currently trades at $1.37 per share with a market capitalization of $192,672,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 46/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 12.4x, below its 5-year median of 13.2x.
Looking at its own history, OGI is currently trading cheaper than 88% of the last 5Y on P/E. This places it in the 13th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates OGI's intrinsic value at $8.54 per share, against the current market price of $1.37. This implies a margin of safety of +84.66%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 0/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: OGI appears richly valued on our framework, with a Smart Value Score of 46/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is OGI overvalued in 2026?
Based on a Smart Value Score of 46/100, OGI appears overvalued. Current price exceeds what fundamentals currently justify.
What is OGI's fair value?
Our DCF model estimates OGI's intrinsic value at $8.54 per share, versus the current price of $1.37. This produces a margin of safety of +84.66%.
What P/E ratio does OGI trade at?
OGI trades at a P/E of 12.4x on trailing twelve-month earnings, compared to its 5-year median of 13.2x.
Is OGI a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 46/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does OGI's valuation compare to its history?
On P/E, OGI currently sits in the 13th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is OGI's Smart Value Score?
OGI's Smart Value Score is 46/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.